Related Experiment Video
Updated: Aug 6, 2026

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
Published on: March 16, 2022
Pathogenic POLRMT variants in mice impair mtDNA transcription and affect perinatal survival
David Alsina1,2, Diana Rubalcava-Gracia3, Kristina Bubb1
1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Abstract:
Mitochondrial gene expression is essential for oxidative phosphorylation that generates the bulk of the cellular ATP, and mitochondrial dysfunction is a common cause of human metabolic diseases. Recently, the first pathogenic variants in the only known mitochondrial RNA polymerase (POLRMT) were described in patients presenting with a wide variety of clinical manifestations, including hypotonia, short stature, and developmental delay. Here, we modeled two human pathogenic POLRMT variants by creating the corresponding substitutions in mice: the dominant S582F and the recessive R984C variant. Mice homozygous for the R984C variant showed perinatal lethality without apparent embryonic developmental defects, a finding consistent with a failure to adapt to the metabolic transition to oxidative metabolism at birth. Mice carrying the S582F variant were viable and exhibited decreased mitochondrial transcript levels due to impaired de novo transcription. However, mtDNA levels and in organello mtDNA replication remained normal, which recapitulates the molecular phenotypes observed in patients. Altogether, our findings indicate that the conserved arginine near the active site is essential for POLRMT function, while the serine in the intercalating hairpin of the N-terminal domain is required for near-genome length transcription but not primase activity. This study highlights genotype-phenotype differences and provides new insights into POLRMT function.
Insights
Mice modeling human mitochondrial RNA polymerase (POLRMT) variants reveal critical roles for POLRMT in metabolic adaptation and transcription. Pathogenic variants cause severe phenotypes, impacting cellular energy production and leading to disease.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Mitochondrial gene expression is vital for cellular ATP production through oxidative phosphorylation.
- Mitochondrial dysfunction is implicated in numerous human metabolic diseases.
- Pathogenic variants in mitochondrial RNA polymerase (POLRMT) have been linked to diverse clinical symptoms.
Purpose of the Study:
- To model two human pathogenic POLRMT variants (S582F and R984C) in mice.
- To investigate the functional consequences of these variants on mitochondrial transcription and cellular metabolism.
- To understand the genotype-phenotype correlations in POLRMT-associated diseases.
Main Methods:
- Creation of mouse models harboring specific POLRMT substitutions (S582F and R984C).
- Assessment of embryonic development, perinatal lethality, and metabolic transition at birth.
- Quantification of mitochondrial transcript levels, mtDNA levels, and in organello mtDNA replication.
Main Results:
- Homozygous R984C variant mice exhibited perinatal lethality, suggesting impaired adaptation to oxidative metabolism.
- S582F variant mice showed reduced mitochondrial transcript levels due to impaired de novo transcription, with normal mtDNA levels and replication.
- The study identified distinct molecular phenotypes correlating with specific POLRMT variants.
Conclusions:
- The conserved arginine residue is crucial for POLRMT's overall function.
- The serine residue is essential for full-length mitochondrial transcription but not primase activity.
- This research provides insights into POLRMT function, genotype-phenotype relationships, and mitochondrial diseases.
Related Concept Videos
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Animal Mitochondrial Genetics
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Abnormal Proliferation

